- [Resource Hub](/)
- [Resource](/?resource-type=poster#library)
- Integrative spatial profiling of protein and chromosomal alterations across normal, precancer, and cancer revealed the presence of aneuploidy in the normal fallopian tube

# Integrative spatial profiling of protein and chromosomal alterations across normal, precancer, and cancer revealed the presence of aneuploidy in the normal fallopian tube

Aneuploidy is treated as a hallmark of cancer, yet this AACR 2026 poster from Harvard Medical School's Laboratory of Systems Pharmacology uses a single-section ORION-FISH workflow, pairing one-shot Orion multiplexed protein imaging with a 4-plex DNA-FISH assay, to reveal that chromosomal copy-number changes already arise in morphologically normal fallopian tube epithelium along the path to high-grade serous ovarian cancer.

Presented by Harvard Medical School.

Read or download to see:

- Aneuploidy was detected in morphologically normal fallopian tube epithelium, not only in invasive cancer. Across a normal-precancer-cancer continuum in high-grade serous ovarian carcinoma (HGSOC), cells carrying extra copies of MYC (8q24) and CCNE1 (19q12) were found in morphologically normal fallopian tube epithelium adjacent to serous tubal intraepithelial carcinoma (STIC) lesions across three incidental STIC cases (n=3), and these cells sat under active immune surveillance.

- A single ORION-FISH workflow reads protein state and chromosomal copy number from the same tissue section. It pairs one-shot Orion multiplexed immunofluorescence (a 16-18-plex antibody panel) with a morphology-preserving 4-plex DNA-FISH assay (MYC/CEP8 and CCNE1/CEP19) on the same FFPE slide, keeping the antigenicity and nuclear morphology that conventional DNA-FISH destroys through protease digestion and permeabilization.

- ORION-FISH copy-number calls matched a clinically approved FISH platform on known-amplified control cases. Validated against clinically approved BioView scoring at 60X (1.42 NA oil objective), ORION-FISH scored extra copies (more than 5 per cell) of MYC in 29% and CCNE1 in 26% of cells in the MYC/CCNE1-amplified HGSOC-1 case, and MYC in 39% and CCNE1 in 9% in the MYC-gain HGSOC-3 case.

[Download poster](https://cdn.sanity.io/files/s3p6uqps/production/c2e2fde8a721b66ae4c301cecadcb22b6800922d.pdf)

Your browser doesn’t support embedded PDFs.
[Download the poster](https://cdn.sanity.io/files/s3p6uqps/production/c2e2fde8a721b66ae4c301cecadcb22b6800922d.pdf) to view it.

[Back to all resources](/#library)
## Related resources
[Article](https://www.selectscience.net/article/advanced-spatial-biology-sheds-new-light-on-therapeutic-research) Orion SelectScience
### Advanced spatial biology sheds new light on therapeutic research
[Read Article](https://www.selectscience.net/article/advanced-spatial-biology-sheds-new-light-on-therapeutic-research) [Article](https://www.selectscience.net/editorial-articles/bringing-spatial-biology-to-the-clinic-a-new-lens-on-cancer-biology/?&artID=58147) Orion SelectScience
### Bringing spatial biology to the clinic: “A new lens on cancer biology”
[Read Article](https://www.selectscience.net/editorial-articles/bringing-spatial-biology-to-the-clinic-a-new-lens-on-cancer-biology/?&artID=58147) [Article](https://www.selectscience.net/article/how-to-unlock-the-complexity-of-tumor-microenvironments) Orion SelectScience
### How to unlock the complexity of tumor microenvironments
[Read Article](https://www.selectscience.net/article/how-to-unlock-the-complexity-of-tumor-microenvironments) [Brochure](https://go.pardot.com/l/455452/2020-07-15/8p7453/455452/1606951069teslfZQe/BR21_101_Orion_Brochure_201202.pdf) Orion
### Orion Spatial Proteomics Platform
[View Brochure](https://go.pardot.com/l/455452/2020-07-15/8p7453/455452/1606951069teslfZQe/BR21_101_Orion_Brochure_201202.pdf) [Spec Sheet](https://pardot.rarecyte.com/l/455452/2026-02-24/965v3w/455452/1771949067AeuR6syb/Orion_HT_spec_sheet.pdf) Orion
### Orion HT
[View Spec Sheet](https://pardot.rarecyte.com/l/455452/2026-02-24/965v3w/455452/1771949067AeuR6syb/Orion_HT_spec_sheet.pdf) [Spec Sheet](https://pardot.rarecyte.com/l/455452/2025-10-31/961nyb/455452/1761933957WEJWJyeN/2025.07.14___SS___Orion__LE_.pdf) Orion
### Orion LE
[View Spec Sheet](https://pardot.rarecyte.com/l/455452/2025-10-31/961nyb/455452/1761933957WEJWJyeN/2025.07.14___SS___Orion__LE_.pdf) [Spec Sheet](https://go.pardot.com/l/455452/2020-07-15/8p742r/455452/1607104572nfrlJouR/DF_24_101_201203_Orion_Datafile.pdf) Orion
### Orion
[View Spec Sheet](https://go.pardot.com/l/455452/2020-07-15/8p742r/455452/1607104572nfrlJouR/DF_24_101_201203_Orion_Datafile.pdf) [Research Spotlight](/resources/spatial-profiling-immune-correlates-mss-crc/) Orion 2026
### Spatial Profiling Uncovers Immune Correlates of Durable Response in Phase 1/2 MSS Colorectal Cancer Trial
[Read Spotlight](/resources/spatial-profiling-immune-correlates-mss-crc/) [Publication](/resources/copanlisib-nivolumab-microsatellite-stable-colorectal/) Orion Nature Communications 2026
### Copanlisib in combination with nivolumab for microsatellite stable colorectal cancer: a phase 1/2 trial
[Read More](/resources/copanlisib-nivolumab-microsatellite-stable-colorectal/) [Publication](https://doi.org/10.1158/2159-8290.CD-26-0171) Orion Cancer Discovery 2026
### Spatial Integration of Protein and Chromosomal States Reveals Early Copy-Number Changes and Genotype-Associated Immune Neighborhoods in Serous Ovarian Cancer Evolution
[View Publication](https://doi.org/10.1158/2159-8290.CD-26-0171) [Publication](https://www.nature.com/articles/s41467-026-74933-w) Orion Nature Communications 2026
### Multiple human transgenes prolong survival of triple-carbohydrate knockout porcine kidney xenografts in nonhuman primates
[View Publication](https://www.nature.com/articles/s41467-026-74933-w) [Video](https://www.youtube.com/watch?v=KOiToZIGN0g) Orion 2026
### Dr. Tanjina Kader on mapping spatial proteomics and chromosomal changes on the same tissue section
[Watch Video](https://www.youtube.com/watch?v=KOiToZIGN0g)